AVDL - Avadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10 May, 04 2023 05:19 PM Avadel Pharmaceuticals plc 2023-05-04 17:19:47 ET Avadel Pharmaceuticals press release ( NASDAQ: AVDL ): Q1 GAAP EPS of -$0.48 misses by $0.10 . Cash, cash equivalents and marketable securities were $100.9 million as of March 31, 2023. The For further details see: Avadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10